Document Detail


Effects of chemotherapy during pregnancy on the maternal and fetal heart.
MedLine Citation:
PMID:  22508540     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The co-occurrence of cancer and pregnancy is more frequently diagnosed. The effects of cancer treatment on maternal and fetal outcomes are less well known. The cardiotoxic effects of chemotherapy are a specific concern for the mother and fetus. We wanted to review the existing literature, mainly consisting of case reports, case studies, and retrospective data.
RESULTS: Maternal effects Overall, the published data indicate that pregnancy is not an independent risk factor influencing cancer survival. There is no indirect evidence for an increased risk for maternal chemotherapy-related cardiotoxicity. Fetal effects During the first trimester chemotherapy needs to be avoided because of teratogenic risks. The risks of chemotherapy during the second and third trimester are more controversial. It has been associated with intrauterine growth restriction and preterm delivery in some studies, while others did not find the same effect. Cardiotoxic fetal effects have been reported despite the limited transplacental passage of chemotherapy. In most patients this was transient and long-term data are generally reassuring.
CONCLUSION: A specific strategy for monitoring fetal and maternal chemotherapy-induced cardiotoxicity is suggested. Prospective data are needed on the long-term effects of chemotherapy in both mother and child.
Authors:
Mina Mhallem Gziri; Frédéric Amant; Frédéric Debiève; Kristel Van Calsteren; Luc De Catte; Luc Mertens
Publication Detail:
Type:  Journal Article; Review     Date:  2012-04-17
Journal Detail:
Title:  Prenatal diagnosis     Volume:  32     ISSN:  1097-0223     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-07-03     Completed Date:  2012-11-29     Revised Date:  2013-05-08    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  England    
Other Details:
Languages:  eng     Pagination:  614-9     Citation Subset:  IM    
Copyright Information:
© 2012 John Wiley & Sons, Ltd.
Affiliation:
Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anthracyclines / adverse effects
Antibodies, Monoclonal, Humanized / adverse effects
Antineoplastic Agents / adverse effects*
Cardiotoxins / adverse effects*
Female
Fetal Diseases / etiology*
Fetal Heart / drug effects*
Heart / drug effects*
Humans
Pregnancy
Pregnancy Complications, Neoplastic / drug therapy*
Chemical
Reg. No./Substance:
0/Anthracyclines; 0/Antibodies, Monoclonal, Humanized; 0/Antineoplastic Agents; 0/Cardiotoxins; P188ANX8CK/trastuzumab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cytologic and histologic findings of iron pill-induced injury of the lower respiratory tract.
Next Document:  Highly Efficient Ring-Opening Reaction of Azlactone-Based Copolymer Platforms for the Design of Func...